Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Cannabis withdrawal syndrome real but underrecognized

Publish date:: June 14, 2019

Key clinical point: Marijuana withdrawal syndrome is a real thing and is associated with psychiatric comorbidities.

Major finding: Frequent cannabis users who experience withdrawal are more prone to mood disorders (adjusted odds ratio, 1.9-2.6), anxiety disorders (aOR, 2.4-2.5), and personality disorders (aOR, 1.7-2.2).

Study details: Review of 1,527 people who participated in the National Epidemiologic Survey on Alcohol and Related Conditions-III.

Disclosures: The work was funded by the National Institute on Drug Abuse. The lead investigator had no disclosures.

Citation:

REPORTING FROM APA 2019

This Week's Must Reads

MDD: Modest improvements in female sexual functioning with adjunctive brexpiprazole,

Transcranial direct current stimulation not clinically relevant in MDD,

Interleukin-1 β and TNF-α hamper antidepressant response in MDD,

Impact of pimavanserin on anxious depression in patients with MDD,

Prior MDD moderates the association between endothelin-1 and post-ACS depressive symptoms,

Must Reads in Addiction Medicine

E-cigarette use tied to increased COPD, asthma risk,

National lung cancer screening guidelines may miss younger African American individuals at high risk,

Alcohol problems linked to legal performance-enhancement products,

Report describes intoxication with new psychoactive substance,

Adolescent alcohol, opioid misuse linked to risky behaviors,